Health-care analyst explains how Big Pharma is approaching coronavirus crisis

The coronavirus outbreak is putting the medical product supply chain in focus after the FDA's recent statement saying it's proactively reaching out to drug and device manufacturers to identify potential disruptions or shortages. Alethia Young, analyst and head of health-care research at Cantor Fitzgerald, joins "Squawk Box" to discuss.
Wed, Feb 19 20209:37 AM EST